Childhood acute leukemia survivors with Down syndrome had increased risk for late mortality not attributable to cardiac- or subsequent ...

Blocking a protein chain reaction makes childhood leukemia cells more sensitive to an existing targeted treatment, a new study shows....

Scientists at St. Jude Children’s Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic...

Patients with Down syndrome have an increased risk for leukemia during childhood, and toxicities related to treatment may be more common...

A molecular building block of many animal proteins, the amino acid valine, plays a key role in cancerous growth seen in T cell acute...

Despite major advances in the treatment of acute lymphoblastic leukemia (ALL), adult survivors face long-term health consequences. A ...

Leukaemic cancer cells can ‘go to sleep’ and thus avoid the effects of chemotherapy, sometimes for years. It turns out that whether the...

Leukemia is the most common childhood cancer. Although advances in treatment have led to high cure rates of childhood leukemia,...

New research published today in JAMA Oncology reports how two separate DNA changes appear to predict aggressive childhood leukemias when...

For the first time, Princess Margaret researchers have mapped out where and how leukemia begins and develops in infants with Down...